Cargando…
Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
In the intensive care unit (ICU) setting, where highly variable and insufficient drug efficacies, as well as frequent and unpredictable adverse drug reactions (ADRs) occur, pharmacogenomics (PGx) offers an opportunity to improve health outcomes. However, PGx has not been fully evaluated in the ICU,...
Autores principales: | Zhou, Shuqin, Skaar, Debra J., Jacobson, Pamala A., Huang, R. Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289166/ https://www.ncbi.nlm.nih.gov/pubmed/30564130 http://dx.doi.org/10.3389/fphar.2018.01436 |
Ejemplares similares
-
Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014) -
Pharmacogenomics of COVID-19 therapies
por: Takahashi, Takuto, et al.
Publicado: (2020) -
Editorial: NSAIDs Pharmacogenomics
por: Agúndez, José A. G., et al.
Publicado: (2021) -
Pharmacogenomics: What is Next?
por: di Iulio, Julia, et al.
Publicado: (2012) -
Addressing disparities in pharmacogenomics through rural and underserved workforce education
por: Brown, Jacob T., et al.
Publicado: (2023)